Peytant Solutions, Inc. - Life Science & Health IT Division Semifinalist

Wednesday, June 27, 2018

Meet Peytant Solutions, Inc. - one of the 10 Semifinalists in MN Cup’s Life Science & Health IT Division! Discover the other Minnesota Cup Semifinalists by browsing our blog and site.

[[{"fid":"130651","view_mode":"default","fields":{"format":"default","alignment":"","field_oc_caption[und][0][value]":"","field_file_image_alt_text[und][0][value]":"logo","field_file_image_title_text[und][0][value]":false,"field_body[und][0][value]":"","external_url":""},"link_text":null,"type":"media","field_deltas":{"1":{"format":"default","alignment":"","field_oc_caption[und][0][value]":"","field_file_image_alt_text[und][0][value]":"logo","field_file_image_title_text[und][0][value]":false,"field_body[und][0][value]":"","external_url":""}},"attributes":{"alt":"logo","style":"height: 64px; width: 350px;","class":"media-element file-default","data-delta":"1"}}]]

Peytant Solutions, Inc. (PSI) is a biomedical device company developing Regenerative Stent Technology™ to improve the treatment of luminal diseases. The Company is a leader in the development of human amniotic tissue covering for alloy stents. Their focus is to commercialize the AMStent® System, a platform technology comprising an amnion-covered stent and catheter delivery system. Amnion is an immune-privileged covering that has the promise to keep vessels open longer with fewer complications than bare metal stents, covered stents, or drug-eluting stents. The AMStent’s performance should improve patency, reduce complications, and decrease interventions, resulting in an attractive value proposition.